Pharmacy Daily | ACCC acts on SensaSlim

THE Australian Competition and Consumer Commission has progressed in its court action against the promoters of the SensaSlim weight loss spray. The ACCC is alleging six cases of misleading and deceptive conduct, including the failure to disclose the involvement of disgraced businessman Peter Foster in its operations. The ACCC is also prosecuting the company for falsely representing that the SensaSlim Spray was the subject of a large worldwide clinical trial when in fact no such trial was conducted. It’s also addressing claims by the company that it had unqualified support as to the effectiveness of the SensaSlim Spray and the purported clinical trials from Australian obesity specialist Dr Matthew Capehorn - claims which the doctor has since refuted. Other points of alleged misleading and deceptive conduct made by SensaSlim according to the ACCC include representing that Michael Boyle was managing the business of SensaSlim; failing to disclose that Boyle was intending to resign as Director immediately following the launch of SensaSlim; and falsely representing that SensaSlim franchisees were already participating in, and profiting from, the SensaSlim franchise, that a SensaSlim franchise had a certain earning potential and that there was a “money back buy back guarantee”.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jul 11
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jul 11